April 1, 2013 by Arezu Sarvestani
Testimony in a the 2nd trial against Johnson & Johnson and its DePuy subsidiary again suggests that the medical device giant knew of potential defects in its metal-on-metal hip implants long before issuing a recall.

Testimony offered last week by former DePuy marketing director Paul Berman claimed that internal emails sent more than a year prior to the initial recall of the ASR XL metal hip implants warned that the product might be defective in design.
No comments:
Post a Comment